Controlled substances are designated as Schedule I-V according to their medical use, potential for abuse and safety or dependence liability.
Pharmatek CEO and CSO Jeffrey Bibbs said the receipt of the additional registration from the DEA demonstrates that they meet the agency’s stringent requirements, and further validates their facility design, security systems, and procedures for analysis, handling, storage and disposal of controlled substances.